Found 4 matching trials
To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric Cancer
PHASE2The safety, tolerability, and determination of the maximum tolerated dose (...
Location
Harbin Medical University Cancer Hospital
To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Metastatic Colorectal Cancer
PHASE2The Phase IIa of this clinical study, a dose-escalation study of IAH0968 in...
Location
The First Hospital of China Medical University
Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors
PHASE1This is a phase I/IIa study to evaluate the safety, tolerability and prelim...
Location
The First Hospital of China Medical University
IAH0968 in Combination With GC for the Treatment of HER2-Positive Unresectable Advanced/Metastatic Malignant Tumors
PHASE1The study aims to evaluate the efficacy and safety of IAH0968 in combinatio...
Location
Fudan University Affiliated Zhongshan Hospital